ReviewCurrent treatment options in oncology2020
Multimodal Therapy for Sinonasal Malignancies: Updates and Review of Current Treatment.
Review in Current treatment options in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- Prevalence and prognostic impact of HPV, EBV, and HIV in head and neck squamous cell carcinoma in the Brazilian Amazon cohort.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026Article
- Preoperative Inflammatory Blood Biomarkers in Sinonasal Carcinoma: A Scoping Review.Medicina (Kaunas, Lithuania) · 2026Article
- Nationwide analysis of olfactory neuroblastoma in Japan: evolving treatment approaches and prognostic outcomes.Japanese journal of clinical oncology · 2026Article
- Paranasal Sinus Squamous Cell Carcinoma and Adenocarcinoma: A SEER Database Analysis.Cancer medicine · 2026Article
- Review
- Identifying chemotherapy beneficiaries in nasal and paranasal sinus cancers: epidemiological trends and machine learning insights.European journal of medical research · 2025Article
- Metastatic olfactory neuroblastoma with unusual solitary metastasis to femur: a case report and literature review.World journal of surgical oncology · 2025Review
- Case Report: Use of submental artery perforator flap for reconstructing defects following sinonasal tumor resection.Frontiers in oncology · 2025Article
- Article
- The role of histology on the outcome of sinonasal carcinomas treated with radiotherapy: a single institution experience.Radiation oncology journal · 2024Article
- Treatment and related morbidity of nasal cavity and paranasal sinus cancers.Frontiers in oncology · 2024Article
- Sox2 and βIII-Tubulin as Biomarkers of Drug Resistance in Poorly Differentiated Sinonasal Carcinomas.Journal of personalized medicine · 2023Article
- Diagnostic performance of MRI for the assessment of extraocular muscle invasion in malignant sinonasal tumors.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2023Article
- Sinonasal malignancies: histopathological entities, regional involvement and long-term outcome.Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale · 2023Article
- Olfactory neuroblastoma: diagnosis, management, and current treatment options.Frontiers in oncology · 2023Review
- Molecular Basis and Rationale for the Use of Targeted Agents and Immunotherapy in Sinonasal Cancers.Journal of clinical medicine · 2022Review
- Evaluation of the Prognostic Capacity of a Novel Survival Marker in Patients with Sinonasal Squamous Cell Carcinoma.Nutrients · 2022Article
- Multi-parametric MRI-based radiomics signature for preoperative prediction of Ki-67 proliferation status in sinonasal malignancies: a two-centre study.European radiology · 2022Article
- The Role of Salvage in the Management of Patients with Sinonasal Squamous Cell Carcinoma.Biomedicines · 2022Article
- Oncologic outcome of multimodality treatment for sinonasal malignancies: An 18-year experience.Frontiers in oncology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
opinion statementSinonasal malignancies pose a significant challenge in management due to their low incidence, biologic diversity, and significant symptom burden. Even though surgery remains the primary therapeutic modality, a multi-modality approach has been shown to benefit a significant proportion of patients and its success depends largely on stage and histologic type. Non-surgical approaches such as novel radiation approaches as well as intensification with systemic therapy hold promise in altering the organ preservation rate as well as overall survival for patients. Practice changing randomized trials to test these novel modalities are overdue and desperately needed.
Indexed as
Identifiers
31950286What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.